Semnur Pharmaceuticals is a specialty pharmaceutical company focusing on clinical and commercial development of innovative products.
Semnur Pharmaceuticals has raised $100.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in September 2025.
Semnur Pharmaceuticals's investors include Vivo Capital, Canaan Partners, Frazier Healthcare Partners.
Semnur Pharmaceuticals is headquartered in Los Altos, United States.
Semnur Pharmaceuticals is a specialty pharmaceutical company focusing on clinical and commercial development of innovative products.
Semnur Pharmaceuticals is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Semnur Pharmaceuticals — Funding & Investors." VCBacked, September 23, 2025, https://www.vcbacked.co/company/semnur-pharmaceuticals. Accessed July 19, 2026.
VCBacked. (2025). Semnur Pharmaceuticals — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/semnur-pharmaceuticals
{{cite web |title=Semnur Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/semnur-pharmaceuticals |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated